⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6406956 | 0.75 | — | — | |
| SCHEMBL7927894 | 0.73 | — | — | |
| SCHEMBL7399131 | 0.68 | — | — | |
| SCHEMBL6721854 | 0.67 | — | — | |
| SCHEMBL18918479 | 0.66 | — | — | |
| SCHEMBL4779243 | 0.66 | — | — | |
| SCHEMBL15520285 | 0.66 | — | — | |
| SCHEMBL1490 | 0.64 | — | — | |
| SCHEMBL10763379 | 0.64 | — | — | |
| SCHEMBL10534579 | 0.64 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 62 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1003904-A4 | COLOR-ENCODING AND IN-SITU INTERROGATION OF MATRIX-COUPLED CHEMICAL COMPOUNDS | BIOARRAY SOLUTIONS LLC (US) | 2004-11-03 | — | — | EP | claimed |
| EP-1003904-A1 | COLOR-ENCODING AND IN-SITU INTERROGATION OF MATRIX-COUPLED CHEMICAL COMPOUNDS | Bioarray Solutions, LLC (US) | 2000-05-31 | — | — | EP | claimed |
| WO-1998053093-A1 | COLOR-ENCODING AND IN-SITU INTERROGATION OF MATRIX-COUPLED CHEMICAL COMPOUNDS | BIOARRAY SOLUTIONS LLC (US) | 1998-11-26 | — | — | WO | claimed |
| EP-2268146-B1 | INDOLINE ANTI-CANCER AGENTS | JOYANT PHARMACEUTICALS INC (US) | 2015-08-26 | — | — | EP | disclosed |
| US-9045401-B2 | Methods for treating or ameliorating a melanoma and killing melanoma cells | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2015-06-02 | — | — | US | disclosed |
| US-8846734-B2 | Diazonamide analogs | JOYANT PHARMACEUTICALS, INC. (US) | 2014-09-30 | — | — | US | disclosed |
| US-20140127155-A1 | Smac mimetic dimers and trimers useful as anti-cancer agents | JOYANT PHARMACEUTICALS, INC (US) | 2014-05-08 | — | — | US | disclosed |
| US-20140100193-A1 | Diazonamide Analogs | JOYANT PHARMACEUTICALS, INC. (US) | 2014-04-10 | — | — | US | disclosed |
| EP-2699580-A2 | DIAZONAMIDE ANALOGS | Joyant Pharmaceuticals, Inc. (US) | 2014-02-26 | — | — | EP | disclosed |
| US-8642554-B2 | Smac mimetic dimers and trimers useful as anti-cancer agents | JOYANT PHARMACEUTICALS, INC. (US) | 2014-02-04 | — | — | US | disclosed |
| US-8592469-B2 | Diazonamide analogs | JOYANT PHARMACEUTICALS, INC. (US) | 2013-11-26 | — | — | US | disclosed |
| WO-2008154441-A1 | METHODS FOR PREPARING DIAZONAMIDES | JOYANT PHARMACEUTICALS, INC. (US) | 2008-12-18 | — | — | WO | disclosed |
| WO-2008147713-A1 | WNT SIGNALING INHIBITORS, AND METHODS FOR MAKING AND USING THEM | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2008-12-04 | — | — | WO | disclosed |
| EP-1996184-A2 | SMALL MOLECULE APOPTOSIS PROMOTERS | Joyant Pharmaceuticals, Inc. (US) | 2008-12-03 | — | — | EP | disclosed |
| WO-2008144747-A2 | LIPOPROTEINS, LIPOPEPTIDES AND ANALOGS, AND METHODS FOR MAKING AND USING THEM | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2008-11-27 | — | — | WO | disclosed |
| WO-2008128121-A1 | SMAC MIMETIC DIMERS AND TRIMERS USEFUL AS ANTI-CANCER AGENTS | JOYANT PHARMACEUTICALS, INC. (US) | 2008-10-23 | — | — | WO | disclosed |
| US-20080051389-A1 | Small molecule apoptosis promoters | JOYANT PHARMACEUTICALS, INC. | 2008-02-28 | — | — | US | disclosed |
| WO-2007136921-A2 | SMALL MOLECULE APOPTOSIS PROMOTERS | JOYANT PHARMACEUTICALS, INC. (US) | 2007-11-29 | — | — | WO | disclosed |
| WO-2007109620-A2 | MACROCYCLIC PEPTIDES AND METHODS FOR MAKING AND USING THEM | SAN DIEGO STATE UNIVERSITY FOUNDATION (US) | 2007-09-27 | — | — | WO | disclosed |
| WO-2004024777-A1 | HYDROXYALKYL STARCH DERIVATIVES | FRESENIUS KABI DEUTSCHLAND GMBH (DE) | 2004-03-25 | — | — | WO | disclosed |